Ketorolac Baxter (Ketorolac Trometamol)

Ketorolac trometamol non‑selectively blocks the cyclooxygenase‑1 and cyclooxygenase‑2 enzymes, which reduces the synthesis of prostaglandins. Lower prostaglandin levels diminish inflammation and decrease the sensitivity of pain‑receiving nerves, providing analgesic and anti‑inflammatory effects.

The specific dose and frequency of Ketorolac Baxter are determined by the prescribing clinician based on the patient’s condition, weight, renal function, and the route of administration. The prescriber will set the appropriate regimen according to clinical guidelines.

Ketorolac is generally avoided in the third trimester of pregnancy because it may affect fetal renal function and prolong labor. Limited data exist for earlier trimesters, and the drug passes into breast milk, so it should be used only if the potential benefit outweighs the risk.

To request Ketorolac Baxter, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed), and import documentation.

Ketorolac is distinguished by its potent analgesic effect, comparable to moderate‑strength opioids, and a rapid onset when given intravenously or intramuscularly. Unlike many NSAIDs, it is typically limited to short‑term use (≤5 days) because of a higher risk of renal and gastrointestinal adverse events.

Ketorolac Baxter should be stored at 2‑8 °C in a refrigerator, protected from light, and must not be frozen or shaken. Keep the vials in their original packaging until use to maintain stability and sterility.

The product is supplied as a sterile solution for intramuscular or intravenous injection. Administration is performed by a qualified healthcare professional, who selects the appropriate route, dose, and infusion rate according to the patient’s clinical needs.

The most serious risks include gastrointestinal bleeding or perforation, acute renal failure, severe allergic reactions such as anaphylaxis, and cardiovascular events like myocardial infarction or stroke, especially with prolonged use or in high‑risk patients.

Ketorolac should be avoided in patients with known hypersensitivity to ketorolac or other NSAIDs, active peptic ulcer disease, significant bleeding disorders, severe renal impairment, third‑trimester pregnancy, and in anyone requiring chronic NSAID therapy beyond five days.